Amedisys, Inc. (NASDAQ:AMED) Shares Sold by MRP Capital Investments LLC

MRP Capital Investments LLC decreased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 97.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 315 shares of the health services provider's stock after selling 12,850 shares during the period. MRP Capital Investments LLC's holdings in Amedisys were worth $29,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Westchester Capital Management LLC grew its stake in shares of Amedisys by 9.5% in the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock valued at $107,976,000 after buying an additional 97,476 shares in the last quarter. Alpine Associates Management Inc. boosted its holdings in Amedisys by 3.2% in the 4th quarter. Alpine Associates Management Inc. now owns 888,120 shares of the health services provider's stock worth $80,632,000 after acquiring an additional 27,403 shares during the period. Wealthfront Advisers LLC acquired a new stake in Amedisys in the fourth quarter valued at approximately $72,970,000. Magnetar Financial LLC raised its stake in shares of Amedisys by 0.3% during the fourth quarter. Magnetar Financial LLC now owns 637,443 shares of the health services provider's stock valued at $57,873,000 after purchasing an additional 1,835 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Amedisys by 1.3% during the third quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider's stock worth $54,746,000 after purchasing an additional 7,071 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Amedisys Stock Up 0.3 %

Amedisys stock traded up $0.29 during midday trading on Monday, hitting $92.67. The stock had a trading volume of 42,119 shares, compared to its average volume of 379,859. The business has a fifty day moving average price of $92.21 and a 200 day moving average price of $92.56. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The stock has a market cap of $3.04 billion, a P/E ratio of 36.77, a P/E/G ratio of 1.78 and a beta of 0.76. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $598.05 million during the quarter, compared to analyst estimates of $602.38 million. Research analysts predict that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Stephens reaffirmed an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a research note on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Amedisys presently has an average rating of "Hold" and a consensus target price of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.